Where is nivolumab made (manufacturing sites)?
Nivolumab is manufactured by Bristol Myers Squibb (BMS). In published product information and regulatory filings, the manufacturing is tied to BMS’s production network and finished-product release through its manufacturing facilities, rather than being described as a single global plant.
Which company’s facilities produce it?
Nivolumab is a BMS product. That means production and release are handled by Bristol Myers Squibb (including contract manufacturing and internal sites used for drug substance and drug product, depending on the country and the specific product presentation).
Does production location vary by country or vial strength?
Yes. Drug product manufacturing and release can vary by country and by presentation (for example, different pack sizes or vial strengths). If you’re trying to pinpoint the exact site for a specific box or batch, the most reliable way is to check the carton label and package insert for the manufacturing/release information tied to that specific product lot.
How can you confirm the exact site for a specific product lot?
Look for “Manufactured by,” “Distributed by,” and/or “Batch/lot released by” statements on the carton and in the accompanying prescribing information. Those documents typically name the relevant manufacturer or release facility for that version of nivolumab.
Related patent/production research
For background on manufacturing, approvals, and related regulatory history, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/